The multivariate analysis showed that some clinical–epidemiological factors such as smoking and high ACPA titers, as well as pulmonary factors such as the UIP radiological pattern and baseline FVC <80%, were associated with poorer pulmonary outcomes at the end of follow-up. The gene discussed is PRTN3; the disease is idiopathic pulmonary fibrosis.